Skip to main content
. 2024 Dec 30;20:586. doi: 10.1186/s12917-024-04450-9

Table 2.

Morphometric changes of developmental changes of Eimeria labbeana-like in the infected and treated pigeon groups

Comparable parameters Experimental groups
Infected Infected + 250 mg/kg MyE Infected + 500 mg/kg MyE Infected + 1 g/L.H2O AMP
Macrogamont Length

11.75 ± 1.53

(10.02–14.84)

10.35 ± 0.40 ab

(9.91–10.94)

9.26 ± 0.30 ab

(8.68–9.67)

7.19 ± 0.43 a

(6.66–7.61)

Width

9.52 ± 0.48

(9.01–10.11)

8.82 ± 0.34 ab

(8.03–9.78)

7.74 ± 0.54 ab

(7.02–8.61)

6.34 ± 0.45 a

(5.33–6.83)

Microgamont Length

12.70 ± 0.69

(12.07–14.17)

11.85 ± 0.30 ab

(11.14–12.75)

10.85 ± 0.50 ab

(10.03–11.86)

9.24 ± 0.47 a

(8.21–9.74)

Width

8.60 ± 0.42

(8.04–9.23)

7.87 ± 0.32 ab

(7.15–8.49)

6.73 ± 0.46 ab

(6.10–7.47)

5.40 ± 0.33 a

(4.81–5.65)

Developing oocyst Length

14.06 ± 0.64

(13.30-14.94)

12.32 ± 0.23 ab

(12.11–13.32)

11.50 ± 0.41 ab

(11.06–12.25)

9.98 ± 0.97 a

(8.98–10.94)

Width

11.49 ± 0.53

(10.70-11.87)

10.45 ± 0.27 ab

(10.21–10.95)

9.80 ± 0.34 ab

(9.71–10.44)

8.39 ± 0.45 a

(7.70–8.98)

All values are in micrometers (µm) and presented as mean ± SD with range in parentheses. a represents the significant change concerning the infected group at p < 0.05, b represents the significant change concerning the infected + 1 g/L.H2O AMP group at p < 0.05